Featured Interview: CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT)

 CEO Dr. Carl Schwartz and Richard Gabriel of Precision Therapeutics Inc. (NASDAQ: AIPT), join the show to talk in detail about the state of the recent merger, new technology for tumor and cancer testing, and plans for 2019.

The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.